Pulmatrix, Inc.
PULM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001574235
No open-market purchases or sales by Pulmatrix, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $568.7K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Pulmatrix, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 15 | 15 | 0 |
| Shares | 329.5K | 334.5K | +5.01K (+1.5%) |
| Value | $425.1K | $568.7K | +$143.6K (+33.8%) |
New holders (2)
Institutions that held Pulmatrix, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Shay Capital LLC | 18,857 | $32.1K | 0.00% |
| Barclays PLC | 15 | $26 | 0.00% |
Sold out (2)
Institutions that held Pulmatrix, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Jane Street Group, LLC | 14,584 | $18.8K |
| Tower Research Capital LLC (TRC) | 207 | $267 |